In the future, we can expect that fewer patients will receive (MHVs), given that surgical repair often is possible in patients with mitral valve disease and a bioprosthetic valve is appropriate in ...

Background—The clinical relevance of Doppler ... valve type, patients’ age, sex, cardiac rhythm, or international normalized ratio were evident between neurologically symptomatic (n=42) and ...

Aortic valve replacement is the second most common cardiothoracic procedure in the UK. With an ageing population, there are an increasing number of patients with prosthetic valves that require ...

Aortic valve prosthesis was inserted retrograde using a femoral arterial or a subclavian artery approach. Results In 44 consecutive patients (mean age 79.1±7 years, 50% women, mean left ventricular ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to ...

Introduction Conductive disturbances requiring permanent pacemaker (PPM) implantation remain a major concern after transcatheter aortic valve implantation (TAVI ... The ratio of prosthesis area to ...

Elevated Doppler velocities across a prosthesis are often a clue to the presence of ... the anteriorly located aortic valve, the anterolaterally located LA appendage, and the medially located atrial ...

Get Instant Summarized Text (Gist) The FDA has approved the SAPIEN 3 TAVR platform for patients with severe asymptomatic aortic stenosis. In a median 3.8-year follow-up, TAVR reduced the combined ...

Citation: Early transcatheter aortic valve replacement reduces cardiovascular events in asymptomatic aortic stenosis patients (2025, May 2) retrieved 24 May 2025 from https://medicalxpress.com ...

A transcatheter aortic valve replacement platform was approved for severe asymptomatic aortic stenosis. Edwards Lifesciences’ TAVR platform is the first to be approved in this population.